Ventyx Biosciences Inc (VTYX)
4.75
+0.07
(+1.50%)
USD |
NASDAQ |
May 02, 12:28
Ventyx Biosciences Price: 4.75 for May 2, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 01, 2024 | 3.78 | 4.912 | 3.70 | 4.68 | 2.025M |
| Apr 30, 2024 | 3.80 | 3.96 | 3.70 | 3.74 | 2.857M |
| Apr 29, 2024 | 3.94 | 4.045 | 3.82 | 3.835 | 947340.0 |
| Apr 26, 2024 | 4.04 | 4.08 | 3.925 | 3.93 | 529730.0 |
| Apr 25, 2024 | 4.15 | 4.15 | 3.94 | 4.06 | 586706.0 |
| Apr 24, 2024 | 4.32 | 4.45 | 4.22 | 4.24 | 596383.0 |
| Apr 23, 2024 | 4.34 | 4.42 | 4.26 | 4.35 | 445605.0 |
| Apr 22, 2024 | 4.50 | 4.54 | 4.23 | 4.30 | 1.100M |
| Apr 19, 2024 | 4.33 | 4.63 | 4.26 | 4.47 | 906049.0 |
| Apr 18, 2024 | 4.37 | 4.48 | 4.235 | 4.35 | 849902.0 |
| Apr 17, 2024 | 4.76 | 4.768 | 4.36 | 4.38 | 780158.0 |
| Apr 16, 2024 | 4.62 | 4.82 | 4.55 | 4.76 | 661262.0 |
| Apr 15, 2024 | 4.64 | 4.83 | 4.595 | 4.67 | 628944.0 |
| Apr 12, 2024 | 4.57 | 4.68 | 4.50 | 4.60 | 674166.0 |
| Apr 11, 2024 | 4.83 | 4.83 | 4.53 | 4.60 | 1.292M |
| Apr 10, 2024 | 4.83 | 4.91 | 4.59 | 4.75 | 1.249M |
| Apr 09, 2024 | 4.69 | 5.20 | 4.62 | 5.04 | 2.023M |
| Apr 08, 2024 | 4.82 | 4.99 | 4.71 | 4.72 | 836059.0 |
| Apr 05, 2024 | 4.94 | 5.13 | 4.68 | 4.84 | 833196.0 |
| Apr 04, 2024 | 5.08 | 5.35 | 4.86 | 4.90 | 1.215M |
| Apr 03, 2024 | 5.26 | 5.35 | 5.18 | 5.18 | 1.191M |
| Apr 02, 2024 | 5.50 | 5.535 | 5.03 | 5.24 | 1.720M |
| Apr 01, 2024 | 5.45 | 5.88 | 5.34 | 5.59 | 3.124M |
| Mar 28, 2024 | 5.82 | 5.96 | 5.43 | 5.50 | 2.205M |
| Mar 27, 2024 | 5.87 | 6.065 | 5.69 | 5.805 | 1.370M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.90
Minimum
Jan 18 2024
46.65
Maximum
Mar 03 2023
21.54
Average
19.76
Median
Price Benchmarks
| Anavex Life Sciences Corp | 3.69 |
| CERo Therapeutics Holdings Inc | 1.37 |
| Avinger Inc | 3.735 |
| Checkpoint Therapeutics Inc | 1.415 |
| RAPT Therapeutics Inc | 8.12 |
Price Related Metrics
| Price to Book Value | 1.154 |
| Earnings Yield | -69.47% |
| Market Cap | 281.39M |